| Literature DB >> 31877705 |
Kevin Kress1, Ulrike Weiler1, Sonja Schmucker1, Marjeta Čandek-Potokar2, Milka Vrecl3, Gregor Fazarinc3, Martin Škrlep2, Nina Batorek-Lukač2, Volker Stefanski1.
Abstract
Immunocastration is a sustainable alternative to piglet castration but faces limited market acceptance. The phenomenon of non-responders has not to date been examined in detail, but adverse and stressful housing conditions (e.g., mixing of groups) might impair the success of vaccinations. Therefore, we evaluated the influence of housing conditions on the immune response after two Improvac® vaccinations at an age of 12 and 22 weeks, respectively. Boars, immunocastrates and barrows (n = 48 each) were assigned to three different housing conditions (n = 36 enriched, n = 36 standard n = 72 repeated social mixing). Immune response was quantified by measuring GnRH-binding and its consequences for testosterone concentrations, development of the genital tract and boar taint. Growth performance was evaluated via average daily gain (ADG). GnRH-binding and testosterone levels revealed that immunocastration reliably suppressed testicular functions after the 2nd vaccination. Housing conditions did not modify testicular function but influenced ADG as animals under mixing grew slower than those under enriched conditions. Gonadal status had only a slight impact on ADG except in immunocastrates, which showed a temporarily higher ADG after the 2nd vaccination. The results show that immunocastration is a reliable procedure under different housing conditions and competitive in terms of growth performance.Entities:
Keywords: Improvac; boar taint; genital tract; growth performance; housing conditions; immune response; immunocastration; non-responder; surgical castration; vaccination
Year: 2019 PMID: 31877705 PMCID: PMC7022942 DOI: 10.3390/ani10010027
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Figure 1Generalized timeline of the trials (feeding periods, blood samples (B1–B4), vaccination times (V1—applied immediately after B1, V2), mixing periods, and slaughter dates according to the age (weeks) of the animals).
Figure 2Plasma testosterone concentrations of boars, immunocastrates and barrows (n = 48 per sex group) at four blood sample time points (B1: before V1, B2: before V2, B3: 2 weeks after V2, B4 at slaughter). Testosterone concentrations between different sex groups with different superscripts differ significantly (p < 0.05).
Figure 3GnRH-binding in immunocastrates under three different housing conditions (enriched—n = 12, standard—n = 12 and mixing—n = 24) at four blood sample time points (B1: before V1, B2: before V2, B3: 2 weeks after V2, B4: at slaughter). Differences between housing groups marked with ns are not significant.
Genital tract weight (g) of boars, immunocastrates and barrows (n = 48 per sex group) housed under three different housing conditions (enriched—n =12, standard—n = 12 and mixing—n = 24).
| Parameter | Boars ( | Immunocastrates ( | Barrows ( | Enriched ( | Standard ( | Mixing ( | ||
|---|---|---|---|---|---|---|---|---|
| Testes * | 722.57 ± 21.43 b | 288.41 ± 20.77 a | - |
| 490.97 ± 26.65 | 521.02 ± 24.23 | 504.48 ± 23.91 |
|
| Vesicular gl. | 274.15 ± 16.26 b | 38.94 ± 15.59 a | - |
| 140.04 ± 19.89 | 175.95 ± 19.15 | 153.63 ± 15.79 |
|
| Bulbourethral gl. | 158.36 ± 10.87 b | 58.95 ± 10.87 a | - |
| 105.42 ± 11.51 | 115.65 ± 11.37 | 104.90 ± 10.67 |
|
| Prostate | 9.24 ± 0.47 b | 3.38 ± 0.46 a | - |
| 6.18 ± 0.53 | 6.85 ± 0.53 | 5.89 ± 0.50 |
|
| Urogenital tract | 540.61 ± 20.46 c | 214.01 ± 18.16 b | 115.41 ± 17.85 a |
| 281.00 ± 18.63 | 310.67 ± 18.68 | 278.36 ± 15.98 |
|
Parameters within a row with different superscripts differ significantly (p < 0.05); * both testes weighed with epididymes.
Androstenone and skatole concentrations in boars, immunocastrates and barrows (n = 48 per sex group) housed under three different housing conditions (enriched—n = 12, standard—n = 12 and mixing—n = 24).
| Parameter | Boars ( | Immunocastrates ( | Barrows ( | Enriched ( | Standard ( | Mixing ( | ||
|---|---|---|---|---|---|---|---|---|
| Androstenone | 2.53 ± 0.50 b | <0.24 a | - | <.0001 | 0.64 ± 0.15 | 0.67 ± 0.15 | 0.74 ± 0.14 | 0.7184 |
| Skatole | 0.037 ± 0.005 b | 0.020 ± 0.003 a | 0.021 ± 0.003a | <.001 | 0.021 ± 0.003 | 0.029 ± 0.005 | 0.025 ± 0.003 | 0.1179 |
Parameters within a row with different superscripts differ significantly (p < 0.05). All immunocastrates had androstenone levels below the limit of detection (<0.24 µg/g fat). Androstenone is testis-derived and was not analyzed in barrows.
Cortisol levels in boars, immunocastrates and barrows (n = 48 per sex group) housed under three different housing conditions (enriched—n = 12, standard—n = 12 and mixing—n = 24).
| Parameter | Boars ( | Immunocastrates ( | Barrows ( | Enriched ( | Standard ( | Mixing ( | ||
|---|---|---|---|---|---|---|---|---|
| Cortisol - B1 | 27.96 ± 2.77 | 26.37 ± 2.75 | 28.93 ± 2.74 |
| 31.76 ± 2.94 | 26.34 ± 2.87 | 25.16 ± 2.49 |
|
| Cortisol - B2 | 23.82 ± 3.04 | 21.37 ± 3.03 | 27.31 ± 3.03 |
| 23.44 ± 3.19 | 23.82 ± 3.13 | 25.23 ± 2.81 |
|
| Cortisol - B3 | 19.49 ± 1.47 | 18.56 ± 1.40 | 17.77 ± 1.34 |
| 17.63 ± 1.46 | 21.49 ± 1.78 | 16.97 ± 0.99 |
|
| Cortisol - B4 | 59.15 ± 4.41 b | 45.29 ± 4.36 a | 49.74 ± 4.34 ab |
| 53.57 ± 4.66 | 48.26 ± 4.61 | 52.36 ± 3.86 |
|
Blood Samples—B1: before V1, B2: before V2, B3: 2 weeks after V2, B4 at slaughter; parameters within a row with different superscripts differ significantly (p < 0.05).
Growth performance (average daily gain, ADG, in g) in boars, immunocastrates and barrows (n = 48 per sex group housed under three different housing conditions (enriched—n = 12, standard—n = 12 and mixing—n = 24).
| Parameter | Boars ( | Immunocastrates ( | Barrows ( | Enriched ( | Standard ( | Mixing ( | ||
|---|---|---|---|---|---|---|---|---|
| ADG - Phase 1 | 854 ± 23 | 864 ± 22 | 911 ± 22 |
| 862 ± 23 | 887 ± 23 | 880 ± 21 |
|
| ADG - Phase 2 | 923 ± 46 | 905 ± 46 | 963 ± 46 |
| 969 ± 47b | 926 ± 47 ab | 894 ± 44 a |
|
| ADG - Phase 3 | 869 ± 20 b | 967 ± 20 c | 816 ± 20 a |
| 911 ± 21 b | 882 ± 21ab | 859 ± 18a |
|
| ADG - Total Fattening | 855 ± 20 | 906 ± 20 | 879 ± 20 |
| 898 ± 21 | 885 ± 21 | 886 ± 19 |
|
Feeding phases: Phase 1—at an age of 10 to 18 weeks; Phase 2: at an age of 18 to 22 weeks; Phase 3—at an age of 22 to 27/28 weeks; Total fattening period: ADG (g) of total fattening period (age of 10 to 27/28 weeks); parameters within a row with different superscripts differ significantly (p < 0.05).